Share
HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient
GPx (@GPx_Boston) / X
Blood-based biomarkers as a promising tool for early detection of
Molecules December-1 2022 - Browse Articles
GPx (@GPx_Boston) / X
YMJ :: Yonsei Medical Journal
PDF) Association of Vegetable and Fruit Consumption with Urinary
Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots
Molecules, Free Full-Text
Sensors, Free Full-Text
Molecules, Free Full-Text
Molecules December-1 2022 - Browse Articles
Related products
You may also like
